Terms: = Breast cancer AND BUB1B, BUBR1, 701, ENSG00000156970, SSK1, BUB1beta, MAD3L, hBUBR1, Bub1A, O60566 AND Clinical Outcome
6 results:
1. Identification of potential key genes for HER-2 positive breast cancer based on bioinformatics analysis.
Lin Y; Fu F; Lv J; Wang M; Li Y; Zhang J; Wang C
Medicine (Baltimore); 2020 Jan; 99(1):e18445. PubMed ID: 31895772
[TBL] [Abstract] [Full Text] [Related]
2. Non-linear transformations of age at diagnosis, tumor size, and number of positive lymph nodes in prediction of clinical outcome in breast cancer.
Forsare C; Bak M; Falck AK; Grabau D; Killander F; Malmström P; Rydén L; Stål O; Sundqvist M; Bendahl PO; Fernö M
BMC Cancer; 2018 Dec; 18(1):1226. PubMed ID: 30526533
[TBL] [Abstract] [Full Text] [Related]
3. Therapeutic Potentials of BDNF/TrkB in breast cancer; Current Status and Perspectives.
Tajbakhsh A; Mokhtari-Zaer A; Rezaee M; Afzaljavan F; Rivandi M; Hassanian SM; Ferns GA; Pasdar A; Avan A
J Cell Biochem; 2017 Sep; 118(9):2502-2515. PubMed ID: 28230291
[TBL] [Abstract] [Full Text] [Related]
4. Prognostic implications of securin expression and sub-cellular localization in human breast cancer.
Gurvits N; Repo H; Löyttyniemi E; Nykänen M; Anttinen J; Kuopio T; Talvinen K; Kronqvist P
Cell Oncol (Dordr); 2016 Aug; 39(4):319-31. PubMed ID: 26984614
[TBL] [Abstract] [Full Text] [Related]
5. Transcriptomic analyses identify association between mitotic kinases, PDZ-binding kinase and BUB1, and clinical outcome in breast cancer.
Ocaña A; Pérez-Peña J; Díez-González L; Sánchez-Corrales V; Templeton A; Seruga B; Amir E; Pandiella A
Breast Cancer Res Treat; 2016 Feb; 156(1):1-8. PubMed ID: 26897635
[TBL] [Abstract] [Full Text] [Related]
6. New prognostic factors in breast cancer.
Adam Maciejczyk A
Adv Clin Exp Med; 2013; 22(1):5-15. PubMed ID: 23468257
[TBL] [Abstract] [Full Text] [Related]
